?dT Cell Cancer Immunotherapy

Bol

?d T Cell Cancer Immunotherapy: Evidence-Based Perspectives for Clinical Translation covers and critically discusses the current pre-clinical and clinical ?d T cell landscape. In 9 chapters it not only focuses on the promises of what's to come, but also on the challenges faced by the field, as well as suggestions and discussion around potential solutions by experts in the area. Particular attention is given to summarizing recent advances on what is known about relevant areas of ?d T cell biology on summarizing the 'big picture' clinical situation, an up-to-date systematic clinical trial review covering autologous, allogeneic, engineered and non-engineered therapies and perspectives on the types of cutting-edge gene-engineering that may be required to enhance the effect-size and durability of therapeutic efficacy. Content provides an updated and comprehensive insight into the current state of ?d T cell immunotherapy, providing discussion on the promise as well as challenges of the field that is of interest to existing translational ?d T cell specialists, the proliferating range of academic scientists and commercial scientists entering the field, as well as clinicians who may encounter ?d T cell immunotherapy in the clinic or are wishing to familiarize themselves with non-canonical lymphocyte immunotherapy. Addresses the possible advantage of combining ?d T cell-based immunotherapy with conventional chemotherapy or other therapeutic approaches, such as antiangiogenic drugs Provides an up-to-date and well-rounded discussion of a translationally, commercially and scientifically relevant field Enables users to familiarize themselves with an overview of the most important aspects of the field with ease if they are new to it, or gain an up-to-date objective perspective on various aspects of the field Includes helpful illustrative diagrams covering the breadth of the field, as carried out by leading experts

Amazon

Pages: 208, Hardcover, Academic Press